FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q Report
Go back to FBR Capital Reiterates Outperform on Evoke Pharma (EVOK) Following 2Q ReportEVOKE PHARMA (NASDAQ: EVOK) | Delayed: 0.50 +0.02 (4.17%) | |||||
---|---|---|---|---|---|---|
Previous Close | $0.48 | 52 Week High | $11.11 | |||
Open | $0.50 | 52 Week Low | $1.35 | |||
Day High | $0.50 | P/E | N/A | |||
Day Low | $0.50 | EPS | $-0.57 | |||
Volume | 759 |